Left ventricular assist devices are becoming an increasingly prevalent therapy for patients
with Stage D heart failure with reduced ejection fraction. Technological advances have …

WITHDRAWN: Executive Summary - The International Society for Heart and Lung
Transplantation (ISHLT) guidelines for the care of heart transplant recipients - ScienceDirect Skip …

Hemolysis is an unintended sequel of temporary or permanent intracardiac devices.
However, limited data exist on the characteristics and treatment of hemolysis in patients with …

Background—We evaluated thrombotic and bleeding outcomes in patients with continuous-
flow left ventricular assist devices (CF-LVADs), stratified by anticoagulation intensity …

Iron deficiency is a common and independent predictor of adverse outcomes in patients with
heart failure. The implications of iron deficiency in patients implanted with a left ventricular …

Left ventricular assist devices (LVADs) improve survival in patients with advanced heart
failure. As LVAD use increases, so do the number of patients with LVADs who also have …

Aim: Our study aims to provide a more holistic understanding of the available data and
predictive risk factors for gastrointestinal bleed (GIB). Materials & methods: We searched …

Background—Renal failure requiring renal replacement therapy (RRT) has detrimental
effects on quality of life and survival of patients with continuous-flow left ventricular assist …

Heart failure continues to be a worldwide epidemic, effecting over 23 million persons.
Despite advances in medical therapy, the disease is progressive and a significant proportion …

Background Data on anemia and its effects on patients supported with continuous-flow left
ventricular assist devices (LVADs) are lacking. Objectives This study sought to describe the …